Birdwatch Note Rating
2023-04-09 01:43:57 UTC - HELPFUL
Rated by Participant: BB5E30DF8A98FE8A7F4070009A4AA5DD4209F1621921DF556252B69AE5DE674D
Participant Details
Original Note:
Following publication of new data from a clinical trial looking at the outcome of admission to hospital, WHO now suggests the use of remdesivir in mild or moderate COVID-19 patients who are at high risk of hospitalization. https://www.who.int/news/item/22-04-2022-who-recommends-highly-successful-covid-19-therapy-and-calls-for-wide-geographical-distribution-and-transparency-from-originator
All Note Details